{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:36:13Z","timestamp":1792802173674,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jmii.2022.12.007","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:27:50Z","timestamp":1671190070000},"page":"416-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1589-4425","authenticated-orcid":false,"given":"Ting-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9775-5538","authenticated-orcid":false,"given":"Ya-Chiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-0286","authenticated-orcid":false,"given":"Bor-Luen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jmii.2022.12.007_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology"},{"issue":"9631","key":"10.1016\/j.jmii.2022.12.007_bib2","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jmii.2022.12.007_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jmii.2022.12.007_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.007_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.007_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10067-016-3530-4","article-title":"Juvenile dermatomyositis: a tertiary center experience","volume":"36","author":"Barut","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.007_bib7","first-page":"188","article-title":"Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study","volume":"32","author":"Taborda","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.007_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pedneo.2014.02.006","article-title":"Juvenile dermatomyositis: a 20-year retrospective analysis of treatment and clinical outcomes","volume":"56","author":"Sun","year":"2015","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.007_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.epag.2014.06.001","article-title":"Juvenile dermatomyositis, clinical manifestations and outcome in an Iranian cohort","volume":"62","author":"Saghafi","year":"2014","journal-title":"Egyptian Pediatric Association Gazette"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.007_bib10","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.007_bib11","first-page":"739","article-title":"Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes","volume":"21","author":"Guzman","year":"1994","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.007_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mjd.2001.113686","article-title":"Juvenile dermatomyositis: a retrospective review of a 30-year experience","volume":"45","author":"Peloro","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"10019","key":"10.1016\/j.jmii.2022.12.007_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.007_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of arthritis and Musculoskeletal and skin diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jmii.2022.12.007_bib15","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.007_bib16","first-page":"192","article-title":"The arthritis of inflammatory childhood myositis syndromes","volume":"28","author":"Tse","year":"2001","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.007_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jmii.2022.12.007_bib18","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.3389\/fimmu.2018.02951","article-title":"Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools","volume":"9","author":"Wienke","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.007_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12969-018-0257-6","article-title":"Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria","volume":"16","author":"Hinze","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.007_bib20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/rheumatology\/keu146","article-title":"Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool","volume":"53","author":"Sanner","year":"2014","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.007_bib21","first-page":"603","article-title":"Defining clinical Improvement in Adult and juvenile myositis","volume":"30","author":"Rider","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jmii.2022.12.007_bib22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","article-title":"The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis","volume":"72","author":"Lazarevic","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jmii.2022.12.007_bib23","first-page":"1443","article-title":"Clinical utility of the erythrocyte sedimentation rate","volume":"60","author":"Brigden","year":"1999","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.007_bib24","first-page":"165","article-title":"Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis","volume":"12","author":"Amerio","year":"2002","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.007_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3346\/jkms.2016.31.3.389","article-title":"Elevated erythrocyte sedimentation rate is predictive of interstitial lung disease and mortality in dermatomyositis: a Korean retrospective cohort study","volume":"31","author":"Go","year":"2016","journal-title":"J Kor Med Sci"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.007_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.jmii.2022.12.007_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.007_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.007_bib29","first-page":"119","article-title":"Calcinosis in juvenile dermatomyositis: pathogenesis and current therapies","volume":"1","author":"Rider","year":"2003","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.007_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.007_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1090-3798(98)80021-4","article-title":"Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids","volume":"2","author":"Tabarki","year":"1998","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jmii.2022.12.007_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J Autoimmun"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222002882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222002882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:28:30Z","timestamp":1761658110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222002882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1684118222002882"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2022.12.007","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2022.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}